Chronic Rhinosinusitis Trial, Recruiting NCT07245329 Sponsor: Tongji Hospital Condition: Chronic Rhinosinusitis
Back to Chronic Rhinosinusitis

Chronic Rhinosinusitis Trial, Recruiting

NCT07245329
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • You have been diagnosed with chronic rhinosinusitis with nasal polyps (a condition causing blocked sinuses and growths inside the nose), confirmed using recognised medical guidelines
  • A blood test has shown that you have a higher-than-normal level of a type of white blood cell called eosinophils (confirm with trial site)

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have cystic fibrosis
  • You have a condition called primary ciliary dyskinesia, which affects how tiny hairs in the airways move (confirm with trial site)
  • You have a fungal infection forming a ball-like mass in your sinuses (confirm with trial site)
  • You have a disease that causes inflammation of blood vessels or abnormal clusters of immune cells throughout the body (confirm with trial site)
  • You have or have had cancer
  • Your immune system does not work properly
  • You have had a cold, flu, or other upper airway infection in the last 4 weeks
  • You have a significant ongoing condition affecting the heart, lungs, brain, nerves, blood, gut, or other major body systems that could affect the trial results or your safety (confirm with trial site)
  • You are currently taking part in another clinical trial, have done so in the last 30 days, or you work directly on this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86 15071077020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tongji Hospital
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Numbers and Proportions of Nasal Mucosa inflammatory cells in Patients With Nasal Polyps at Baseline and 1, 3, and 6 Months After Surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov